The Effect of Human Myelomonocytic Leukemic Cell Line (M20) Derived IL-1 Inhibitor on Human Erythroid Cell Development

References

• Treves A. J., Halperin M., Barak V., Bar-Tana R., et al. A new myelomonoblastic cell line (M20): Analysis of properties, differentiation and comparison with other established lines of similar origin. Exp. Hematol. 1985; 13: 281–288
   PubMed Web of Science ®Google Scholar
• Barak V., Treves A. J., Yanai P., Halperin M., Wasserman D., Biran S., Braun S. Interleukin-1 inhibitor activity secreted by a human myelomoncytic cell line (M20). Eur. J. Immunol. 1986; 16: 1449–1452
   PubMed Web of Science ®Google Scholar
• Peritt D., Flechner I., Okunev E., Yanai P., Halperin T., Treves A. J., Barak V. The M20 IL-1 inhibitor: I. Purification by preparative isoelectric focusing in free solution. J. Immunol. Meth. 1992; 155: 159–165
   PubMed Web of Science ®Google Scholar
• Peritt D., Flechner I., Yanai P., Okunev E., Halperin T., Treves A. J., Barak V. The M20 IL-1 inhibitor: II. Biological characterization. J. Immunol. Meth. 1992; 155: 167–174
   PubMed Web of Science ®Google Scholar
• Barak V., Peritt D., Flechner I., Yanai P., Halperin T., Dinarello C. A., Treves A. J. The M20 IL-1 inhibitor prevents onset of adjuvant arthritis. Biotherapy 1992; 4(4)317–323
   PubMedGoogle Scholar
• Barak V., Peritt D., Flechner I., Yanai P., Halperin T., Treves A. J., Dinarello C. A. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist. Lymphokine and Cytokine Res. 1991; 10: 437–442
   PubMedGoogle Scholar
• Peled T., Rigel M., Peritt D., Fibach E., Treves A. J., Barak V. The effect of M20 IL-1 inhibitor on normal and leukemic human myeloid progenitors. Blood 1991; 79: 1172–1177
   Web of Science ®Google Scholar
• Fibach E., Manor D., Oppenheim A., Rachmilewitz E. A. Proliferation and maturation of human erythroid progenitors in liquid medium. Blood 1989; 73: 100–103
   PubMed Web of Science ®Google Scholar
• Fibach E., Manor D., Treves A., Rachmilewitz E. A. Growth of human normal erythroid progenitors in liquid culture: A comparison with colony growth in semisolid culture. Int. J. Cell. Clon. 1991; 9: 57–64
   PubMedGoogle Scholar
• Dinarello C. A. Interleukin 1 and interleukin 1 antagonism. Blood 1991; 77: 1627–1652
   PubMed Web of Science ®Google Scholar
• Orkin S. H., Harosi F. I., Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc. Natl. Acad. Sci. USA 1975; 72: 98–102
   PubMed Web of Science ®Google Scholar
• Fibach E. Measurement of total and fetal hemoglobin in cultured human erythroid cells by a novel micro method. Hemoglobin 1993; 17: 41–53
   PubMed Web of Science ®Google Scholar
• Crown J., Jakubowsky A., Gabrilove J. Interleukin-1: Biological Effects in Human Hematopoiesis. Leukemia and Lymphoma 1993; 9: 433–440
   PubMed Web of Science ®Google Scholar
• Moore M. A. S. Role of interleukin 1 in hematopoiesis. Immunol. Res. 1989; 8: 165–168
   PubMed Web of Science ®Google Scholar
• Bot F. Y., Schipper P., Breeders Z., Delwel R., Kanshansky K., Lowenberg B. Interleukin 1 also induces granulocyte-macrophage colony stimulating factor in immature normal bone marrow cells. Blood 1990; 76: 307–311
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Torcia M., Bettoni S., Rannier E., Barbui T., Shaw A. R., Dinarello C. A., Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by Interleukin 1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991; 78: 3248–3253
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Wetzler M., Kantarjan H., Blake M., Harris D., Gutterman J. U., Talpaz M. Suppression of chronic myelogeneous leukemia colony growth by IL-1 Receptor Antagonist and soluble IL-1 Receptors: a novel application for inhibitors of IL-1 activity. Blood 1991; 78: 1476–1484
   PubMed Web of Science ®Google Scholar
• Zucali J. R., Broxmeyer H. E., Dinarello C. A., Gross M. A., Weiner R. S. Regulation of early human hematopoietic (BFU-e and CFU-GEMM) progenitor cells in vitro by IL-1 induced fibroblast medium. Blood 1987; 69: 33–37
   PubMed Web of Science ®Google Scholar
• Larrick J. W. Native Interleukin-1 inhibitors. Immunol. Today 1989; 10: 61–66
   PubMedGoogle Scholar
• Dayer J. M., Seckinger P. Natural Inhibitors and Antagonists in Interleukin 1, Inflammation and Disease, R. H. R. Bomford, B. Henderson. Elsevier, Amsterdam 1989
   Google Scholar
• Hannum C., Wilcox C., Arend W. P., et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336–340
   PubMed Web of Science ®Google Scholar
• Eisenberg S. P., Evans R. J., Arend W. P., et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341–346
   PubMed Web of Science ®Google Scholar
• Carter D. B., Deibel M. R., Jr, Dunn C. J., Tomich C. S. C., Laborde A. L., Slightom J. L., Berger A. F., Bienkowski M. J., Shely J. A., Eessalv T. E., Taylor B. M., Tracy D. E. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633–638
   PubMed Web of Science ®Google Scholar
• Barak V., Peritt D., Yanai P., Halperin T., Treves A. J. In vivo anti inflammatory effects of the M20 IL-1 Inhibitor. I. Effects on acute inflammatory parameters. Biotherapy 1994; 6: 263–270
   Google Scholar
• Barak V., Gorodetsky R., Weidenfeld J., Peritt D., Yanai P., Halperin T., Treves A. J. In vivo anti inflammatory effects of the M20 IL-1 Inhibitor. II. Effects on serum reactants. Biotherapy 1994; 6: 271–277
   Google Scholar
• Moore M., Warren D. J. Synergy of interleukin-1 and granulocyte colony stimulating factor: In vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. USA 1987; 84: 7134–7138
   PubMed Web of Science ®Google Scholar
• Mityavila M. T., Natazawa M., Brignaschi P., Debili N., Breton-Gorius J., Vainchenker W. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum replaced cultures. J. Cell. Physiol. 1989; 138: 617–623
   PubMed Web of Science ®Google Scholar
• Yin M., Gopal V., Banavali S., Gartside P., Preisler H. Effects of an IL-1 receptor antagonist on acute myeloid leukemia cells. Leukemia 1992; 6: 898–901
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Talpaz M. Role of Interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. Leukemia and Lymphoma 1993; 10: 407–418
   PubMed Web of Science ®Google Scholar